Yaşar Bayindir, Md

This study follows 490 adults with a past hepatitis B infection who need immune-suppressing treatments. Researchers will monitor bone, kidney, and metabolic health over 4 years to understand the long-term safety of antiviral drugs used to prevent hepatitis B reactivation. The goa…